case report
A 29-year-old pregnant woman with 16 weeks of gestation presented to the emergency department of our hospital with complaints of breathlessness, low-grade fever, productive cough, and right-sided chest discomfort of 2-week duration. She had no history of loss of appetite, loss of weight, and hemoptysis. There was no history of similar illness in the past. There was no prior history of diabetes mellitus, bronchial asthma, surgical intervention, or hospitalization.
On general examination, the patient's respiratory rate was 28/min; other vitals were stable. Respiratory examination revealed decreased right-sided chest movements, percussion note was stony dull at right base, and air entry was absent at right base.
Her hematological and biochemical parameters were normal. Serology for human immunodeficiency virus was negative.
A chest radiograph was done, which had features of right-side hydropneumothorax [ Figure 1 ]. Computed tomography chest was not done in view of radiation hazard to the fetus. Ultrasonography (USG) of the chest revealed loculated pleural fluid collection in the posterolateral aspect of the right lower hemithorax [ Figure 2 ]. USG-guided thoracentesis was done which revealed frank brownish fluid following which tube thoracostomy was performed. Pleural fluid was exudative with high adenosine deaminase, and GeneXpert was negative for Mycobacterium tuberculosis (MTB). Pleural fluid and sputum culture revealed significant growth of A. fumigatus. Sputum was negative for other pyogenic organisms and acid-fast bacilli. Sputum for GeneXpert MTB was also negative. Streptokinase was injected through the intercostal drainage tube for adhesiolysis. The lung expanded well and the intercostal drainage tube was removed after 10 days. Repeat chest X-ray after 2 months showed expanded lung with no lesion [ Figure 3 ]. She was treated with intravenous voriconazole initially followed by oral voriconazole. Her voriconazole trough levels and liver function were monitored periodically. She tolerated voriconazole well without any side effects. After 5 months of voriconazole, she delivered a normal live baby by elective cesarean section.
dIscussIon
Pleuropulmonary aspergillosis is a rare entity and usually occurs in the presence of disruption of local pulmonary defense mechanisms, most often due to tuberculosis. Pleural Aspergillosis was first described by Cleland in 1924. [9] Krakówka et al. found that an established empyema and a bronchopleural or pleurocutaneous fistula were the two clinical settings most commonly associated with pleural Aspergillosis. [10] An extensive PubMed search revealed no case report in English literature, with pleuropulmonary Aspergillosis in pregnant women.
Antifungal agents and surgical procedures have been tried in the treatment of pleuropulmonary aspergillosis. To improve the outcome, pleural drainage and early administration of antifungal agents are recommended. [7] Voriconazole is a broad-spectrum triazole which is active against all species of Aspergillus. It has less adverse effects compared to amphotericin. [11] Stern et al. demonstrated that penetration and sterilization of pleural cavity are good with voriconazole, and within 6 months of treatment, the patient was completely cured. [12] Amphotericin also has been used conventionally, but it has more side effects such as (nephrotoxicity, phlebitis, hypokalemia, hypomagnesemia, and anemia). [11] Liposomal amphotericin comparatively is less nephrotoxic.
Initially, medical termination of pregnancy was considered in our patient because of the difficulty in obtaining appropriate investigations such as computed tomography scan of the chest in a pregnant woman and the need for long-term antifungal for the empyema. Voriconazole belongs to the Food and Drug Administration category D for use in pregnancy, and there were anticipated concerns on the fetus. Moreover, Aspergillosis per se may also affect the baby (e.g., intrauterine infection). All these aspects were discussed in detail with the patient and she decided to continue with the pregnancy.
Organogenesis is the process by which three germ layers turn into the internal organs. This period extends from 3 to 10 weeks of pregnancy. During this period, the fetus is most susceptible to malformations from teratogenic agents. However, in our patient, the period of organogenesis was over when we started antifungal therapy, and serial USGs showed no signs of fetal anomalies. The pregnancy was continued, and termination of pregnancy could be avoided. The patient responded well clinically and radiologically to voriconazole therapy and pleural drainage and delivered a normal live baby.
conclusIon
In nonresponsive empyema, fungal cause also should be included in the differential diagnosis. Early diagnosis and treatment with appropriate antifungals and surgical intervention improves the outcome. Monitoring for the side effects of antifungal therapy is important. The management of pleuropulmonary aspergillosis in pregnancy can often be challenging and requires a dedicated multidisciplinary approach.
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